Precision Biosciences (DTIL) Non-Current Debt (2024 - 2026)

Precision Biosciences (DTIL) has 3 years of Non-Current Debt data on file, last reported at $22.4 million in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $22.4 million, changed 0.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.4 million (changed 0.37% YoY), and the FY2025 annual result was $22.4 million, changed 0.37% from the prior year.
• Non-Current Debt held at $22.4 million in Q1 2026 per DTIL's latest filing, from $22.4 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $22.4 million in Q1 2026 and troughed at $22.3 million in Q3 2024.
• A 3-year average of $22.4 million and a median of $22.4 million in 2025 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2025 and 2026: Non-Current Debt climbed 0.43% in 2025, then grew 0.37% in 2026.
• A 3-year view of Non-Current Debt shows it stood at $22.3 million in 2024, then grew by 0.37% to $22.4 million in 2025, then grew by 0.07% to $22.4 million in 2026.
• Business Quant data shows DTIL's Non-Current Debt at $22.4 million in Q1 2026, $22.4 million in Q4 2025, and $22.4 million in Q3 2025.